Preclinical safety of RNAi-mediated HTT suppression in the rhesus macaque as a potential therapy for Huntington's disease

Jodi L. McBride, Mark R. Pitzer, Ryan L. Boudreau, Brett Dufour, Theodore Hobbs, Sergio R. Ojeda, Beverly L. Davidson

    Research output: Contribution to journalArticlepeer-review

    200 Scopus citations

    Fingerprint

    Dive into the research topics of 'Preclinical safety of RNAi-mediated HTT suppression in the rhesus macaque as a potential therapy for Huntington's disease'. Together they form a unique fingerprint.

    Medicine & Life Sciences

    Chemical Compounds